Caring for the smoking asthmatic patient

Slides:



Advertisements
Similar presentations
SMOKING CESSATION: THE MINIMAL CONTACT INTERVENTION.
Advertisements

Tobacco treatment TrAining Network in Crete Tobacco treatment TrAining Network in Crete.
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: A population-based study 
What drives prescription patterns in pediatric asthma management?
Stephen Joseph Galli, MD  Journal of Allergy and Clinical Immunology 
Pharmacologic rationale for treating allergic and nonallergic rhinitis
The Role of the Primary Care Physician in Helping Adolescent and Adult Patients Improve Asthma Control  Barbara P. Yawn, MD, MSc  Mayo Clinic Proceedings 
Asthma diagnosis and treatment: Filling in the information gaps
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Overcoming barriers to nonadherence in asthma treatment
Is 9 more than 2 also in allergic airway inflammation?
Practice Notes from the AAAI
Rising prevalence of asthma is sex-specific in a US farming population
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients  William W. Busse, MD, Sally E. Wenzel, MD, Eli O. Meltzer,
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis  George Philip, MD, Janet van Adelsberg, MD, Thomas Loeys, PhD, Nancy.
Physician needs in health informatics: Just ask the docs
Practice Notes from the AAAAI
Treatment of chronic autoimmune urticaria with omalizumab
Nonadherence to Asthma Treatment: Getting Unstuck
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Immunopathophysiology of food protein–induced enterocolitis syndrome
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
News & Notes Journal of Allergy and Clinical Immunology
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Pinja Ilmarinen, PhD, Leena E
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
What is an “eosinophilic phenotype” of asthma?
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Personalized asthma therapy in blacks—the role of genetic ancestry
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Aaron M. Drucker, MD, Paula J. Harvey, PhD 
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Diagnosis and management of early asthma in preschool-aged children
New pathways for itching in patients with atopic dermatitis?
News Beyond Our Pages Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
The National Institutes of Allergy and Infectious Diseases networks on asthma in inner- city children: An approach to improved care  William W. Busse,
A simulation model of building intervention impacts on indoor environmental quality, pediatric asthma, and costs  Maria Patricia Fabian, ScD, Gary Adamkiewicz,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Advances in basic and clinical immunology in 2013
Pınar Uysal, MD, Esben Eller, MSc, PhD, Charlotte G
Asthma progression: Can we and should we measure it?
Guus A. Westerhof, MD, Elise M. Vollema, MD, Els J
Severity assessment in asthma: An evolving concept
The Editors' Choice Journal of Allergy and Clinical Immunology
National trends in asthma visits and asthma pharmacotherapy,
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Environmental factors and eosinophilic esophagitis
Riccardo Polosa, MD, PhD, James D
News & Notes Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Negative affect, medication adherence, and asthma control in children
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Itching as a systemic disease
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies  Frank C. Albers, MD, PhD, Robert G. Price,
Presentation transcript:

Caring for the smoking asthmatic patient Riccardo Polosa, MD, PhD, Pasquale Caponnetto, PhD, Mark F. Sands, MD  Journal of Allergy and Clinical Immunology  Volume 130, Issue 5, Pages 1221-1224 (November 2012) DOI: 10.1016/j.jaci.2012.04.015 Copyright © 2012 Terms and Conditions

Fig 1 An algorithm for assisting the asthmatic smoker. The first step in treating tobacco use and dependence is to identify tobacco users. Asking systematically whether your asthmatic patients smoke at every visit is imperative (ASK). All smokers with asthma should be advised to quit. This advice should be clearly stated and specifically adapted in relation to the patient’s asthma problems: “Did you know that by quitting you will not only improve your general health status but also your asthma symptoms?” (ADVISE). The willingness of smokers with asthma to make a quit attempt at this time should be assessed (ASSESS). If the patient is ready to quit, health care providers should be prepared to offer assistance. This entails working together with the patient to set a sensible plan with a commitment to a quit date and to frequent follow-up visits. Alternatively, referring the patient to a tobacco intervention resource (eg, a smoking cessation quit line or health educator) that would deliver additional treatment to the patient might be contemplated (ASSIST). All patients who receive a tobacco dependence intervention should be regularly assessed for abstinence, beginning within the first week after the quit date. Abstinent patients should have their quitting success acknowledged. Patients who have relapsed should be assessed to determine whether they are ready to repeat another quit attempt (ARRANGE). Modified from Fiore et al.14 LABA, Long-acting β2-agonist; LTRA, leukotriene receptor antagonist. Journal of Allergy and Clinical Immunology 2012 130, 1221-1224DOI: (10.1016/j.jaci.2012.04.015) Copyright © 2012 Terms and Conditions